International Journal of Scientific & Technology Research

Home About Us Scope Editorial Board Blog/Latest News Contact Us
10th percentile
Powered by  Scopus
Scopus coverage:
Nov 2018 to May 2020


IJSTR >> Volume 5 - Issue 10, November 2016 Edition

International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616

How Can Cosmetics Cause Breast Cancer?

[Full Text]



Cole Thrasher



Breast Cancer, Cosmetics, Parabens, Retinol, Soy, Vitamin A, Dermatology, Oncology



There are approximately 157 million women in America, many of which use cosmetic products daily for anti-aging treatments and overall charismatic improvement in physical appearance. Breast cancer is the second most diagnosed cancer among women in America, slightly trailing behind skin cancer. The research scientists, oncologists, and dermatologists of today have neglected the possible correlation between these cytologic illnesses and the daily behaviors of American women. This research paper is designed to promote awareness among American women and physicians so that modern women are educated on the role of their daily routine in breast cancer development. The integrity of cosmetic products is founded by common ingredients such as parabens, retinol, and even soy. The daily exposure of these potentially toxic substances can result in hormone imbalances, mitotic disruptions, genotoxic influences, and collagen overproduction. Due to these circumstances, the prognosis for most cosmetic-consuming, modern women is grim in terms of breast carcinogenesis.



[1] Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A. D, Karamanos, N. K. (2012). Glycosaminoglycans: Key players in cancer cell biology and treatment. FEBS Journal, 279(7), 1177-1197. doi:10.1111/j.1742-4658.2012.08529.x

[2] Bairati, C., Goi, G., Lombardo, A., Tettamanti, G. (1994). The esters of p-hydroxy-benzoate (parabens) inhibit the release of lysosomal enzymes by mitogen-stimulated peripheral human lymphocytes in culture. Clin. Chim. Acta 224: 147–157.

[3] Byford, J. R., Shaw, L. E., Drew, M. G. B., Pope, G. S., Sauer, M. J., Darbre, P. D. (2002). Oestrogenic activity of parabens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 80: 49–60.

[4] Calvert, P., Yao, K. S., Hamilton, T. C., O’Dwyer, P. J. (1998). “Clinical studies of reversal of drug resistance based on glutathione,” Chemico-Biological Interactions, vol. 111-112, pp. 213–224.

[5] Cipriano, S. D., Kirby, J. S. (2014). Basic Science of the Skin: Structure and Function. American Academy of Dermatology.

[6] Darbre, P. D. (2001). Hypothesis: underarm cosmetics are a cause of breast cancer. Eur. J. Cancer Prevent. 10: 389–393.

[7] Darbre, P. D., Byford, J. R., Shaw, L.E., Hall, S., Coldham, N. G., Pope, G. S., Sauer, M. J. (2003). Oestrogenic activity of benzylparaben. J Appl. Toxicol. 23: 43–51.

[8] Elder, R. L., (1984). Final report on the safety assessment of methylparaben, ethylparaben, propylparaben and butylparaben. J. Ame. Coll. Toxicol. 3: 147–209.

[9] Estrela, J. M., Ortega, A., Obrador, E. (2006). “Glutathione in cancer biology and therapy,”Critical Reviews in Clinical Laboratory Sciences, vol. 43, no. 2, pp. 143–181.

[10] Fang, M., Yuan, J., Peng, C., & Li, Y. (2013). Collagen as a double-edged sword in tumor progression. Tumor Biol. Tumor Biology, 35(4), 2871-2882. doi:10.1007/s13277-013-1511-7

[11] Hossaini, A., Larsen, J. J., Larsen, J. C. (2000). Lack of oestrogenic effects of food preservatives (parabens) in uterotropic assays. Food Chem. Toxicol. 38: 319–323.

[12] Levin, J., Del Rosso, J. Q., & Momin, S. B. (2010). How much do we really know about our favorite cosmeceutical ingredients? Retrieved August 2016, from http://www.ncbi.nlm.nih.gov/pubmed/20725560

[13] Mason, M. M., Cate, C. C., Baker, J. (1971). Toxicology and carcinogenesis of various chemicals used in the preparation of vaccines. Clin. Toxicol. 4: 185–204.

[14] Mukherjee, S., Date, A., Patravale, V., Korting, H. C., Roeder, A., & Weindl, G. (2006). Retinoids in the treatment of skin aging: An overview of clinical efficacy and safety. Clinical Interventions in Aging, 1(4), 327-348. doi:10.2147/ciia.2006.1.4.327

[15] Nakagawa, Y., Maldeus, P. (1998). Mechanism of p-hydroxybenzoate ester-induced mitochondrial dysfunction and cytotoxicity in isolated rat hepatocytes. Biochem. Pharmacol. 55: 1907–1914.

[16] Okubo, T., Yokoyama, Y., Kano, K., Kano I. (2001). ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERα and PR. Food Chem. Toxicol. 39: 1225–1232.

[17] Rastogi, S. C., Schouten, A., De Kruijf, N., Weijland, J. W. (1995). Contents of methyl-, ethyl-, propyl-, butyl- and benzylparaben in cosmetic products. Contact Dermat. 32: 28–30.

[18] Rice, S., Whitehead, S. A. (2006) Phytoestrogens and breast cancer- promoters or protectors? Endocr Relat Cancer. 13:995–1015.

[19] Roos, T. C., Jugert, F. K., Merk, H. F., et al. (1998). Retinoid metabolism in the skin. Pharmacol Rev, 50:315–33

[20] Routledge, E. J., Parker, J., Odum, J., Ashby, J., Sumpter, J. P. (1998). Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol. Appl. Pharmacol. 153: 12–19.

[21] Schwarzman, M. R., Ackerman, J. M., Dairkee, S. H., Fenton, S. E., Johnson, D., Navarro, K. M., . . . Janssen, S. (2015). Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation. EHP Environmental Health Perspectives, 123(12). doi:10.1289/ehp.1408337

[22] Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., . . . Domenicotti, C. (2013). Role of Glutathione in Cancer Progression and Chemoresistance. Oxidative Medicine and Cellular Longevity, 1-10. doi:10.1155/2013/972913

[23] Wolfe, J. N. (1976). Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 7:2486–92.